• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用天然物质靶向程序性细胞死亡(PCD)信号机制治疗糖尿病性心肌病(DCM)。

Targeting the programmed cell death (PCD) signaling mechanism with natural substances for the treatment of diabetic cardiomyopathy (DCM).

作者信息

Xuan Xiaoyu, Zhang Shiliang

机构信息

First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.

Department of Cardiology, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.

出版信息

Phytother Res. 2023 Dec;37(12):5495-5508. doi: 10.1002/ptr.7992. Epub 2023 Aug 25.

DOI:10.1002/ptr.7992
PMID:37622685
Abstract

Diabetic cardiomyopathy (DCM) is one of the severe complications of diabetes, characterized by structural and functional abnormalities in the hearts of diabetic patients without hypertension, coronary heart disease, or valvular heart disease. DCM can progress to heart failure, which is a significant cause of death in diabetic patients, but currently, there is no effective treatment available. Programmed cell death (PCD) is a genetically regulated form of cell death that includes apoptosis, autophagy, necroptosis, ferroptosis, and pyroptosis. PCD is essential for tissue homeostasis and normal development of the body. DCM is a complex condition, and abnormalities in the cascade of PCD signaling have been observed in its pathological process, suggesting that targeting PCD could be a potential therapeutic strategy. Studies have shown that natural substances can effectively modulate PCD to intervene in the treatment of DCM, and their use is safe. This review explores the role of different forms of PCD in the pathogenesis of DCM and summarizes the research progress in targeting PCD with natural substances to treat DCM. It can serve as a basis for further research and drug development to provide new treatment strategies for DCM patients.

摘要

糖尿病性心肌病(DCM)是糖尿病的严重并发症之一,其特征是糖尿病患者的心脏出现结构和功能异常,且无高血压、冠心病或心脏瓣膜病。DCM可进展为心力衰竭,这是糖尿病患者死亡的重要原因,但目前尚无有效的治疗方法。程序性细胞死亡(PCD)是一种由基因调控的细胞死亡形式,包括凋亡、自噬、坏死性凋亡、铁死亡和焦亡。PCD对组织稳态和身体的正常发育至关重要。DCM是一种复杂的病症,在其病理过程中已观察到PCD信号级联的异常,这表明靶向PCD可能是一种潜在的治疗策略。研究表明,天然物质可以有效地调节PCD以干预DCM的治疗,并且其使用是安全的。本综述探讨了不同形式的PCD在DCM发病机制中的作用,并总结了用天然物质靶向PCD治疗DCM的研究进展。它可为进一步的研究和药物开发提供依据,为DCM患者提供新的治疗策略。

相似文献

1
Targeting the programmed cell death (PCD) signaling mechanism with natural substances for the treatment of diabetic cardiomyopathy (DCM).利用天然物质靶向程序性细胞死亡(PCD)信号机制治疗糖尿病性心肌病(DCM)。
Phytother Res. 2023 Dec;37(12):5495-5508. doi: 10.1002/ptr.7992. Epub 2023 Aug 25.
2
The study of the mechanism of non-coding RNA regulation of programmed cell death in diabetic cardiomyopathy.非编码 RNA 调控糖尿病心肌病程序性细胞死亡机制的研究。
Mol Cell Biochem. 2024 Jul;479(7):1673-1696. doi: 10.1007/s11010-023-04909-7. Epub 2024 Jan 8.
3
Role of pyroptosis in diabetic cardiomyopathy: an updated review.细胞焦亡在糖尿病性心肌病中的作用:最新综述。
Front Endocrinol (Lausanne). 2024 Jan 5;14:1322907. doi: 10.3389/fendo.2023.1322907. eCollection 2023.
4
Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death.糖尿病心肌病与细胞死亡:聚焦于金属介导的细胞死亡。
Cardiovasc Toxicol. 2024 Feb;24(2):71-84. doi: 10.1007/s12012-024-09836-7. Epub 2024 Feb 6.
5
Oxidative stress signaling in the pathogenesis of diabetic cardiomyopathy and the potential therapeutic role of antioxidant naringenin.氧化应激信号在糖尿病心肌病发病机制中的作用及抗氧化剂柚皮素的潜在治疗作用。
Redox Rep. 2023 Dec;28(1):2246720. doi: 10.1080/13510002.2023.2246720. Epub 2023 Sep 25.
6
NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy.NLRP3 炎性小体/细胞焦亡:糖尿病心肌病的关键驱动因素。
Int J Mol Sci. 2022 Sep 13;23(18):10632. doi: 10.3390/ijms231810632.
7
Pyroptosis: Mechanisms and links with diabetic cardiomyopathy.细胞焦亡:机制及其与糖尿病心肌病的关联
Ageing Res Rev. 2024 Feb;94:102182. doi: 10.1016/j.arr.2023.102182. Epub 2024 Jan 3.
8
Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy.糖尿病心肌病中存在多种细胞死亡形式的初步证据。
Acta Pharm Sin B. 2022 Jan;12(1):1-17. doi: 10.1016/j.apsb.2021.08.026. Epub 2021 Aug 28.
9
Deciphering The Emerging Role of Programmed Cell Death in Diabetic Wound Healing.解析细胞程序性死亡在糖尿病创面愈合中的新作用。
Int J Biol Sci. 2023 Sep 18;19(15):4989-5003. doi: 10.7150/ijbs.88461. eCollection 2023.
10
Natural compounds target programmed cell death (PCD) signaling mechanism to treat ulcerative colitis: a review.天然化合物靶向程序性细胞死亡(PCD)信号机制治疗溃疡性结肠炎:综述
Front Pharmacol. 2024 Feb 9;15:1333657. doi: 10.3389/fphar.2024.1333657. eCollection 2024.

引用本文的文献

1
The Mechanical Role of YAP/TAZ in the Development of Diabetic Cardiomyopathy.YAP/TAZ在糖尿病心肌病发展中的机械作用
Curr Issues Mol Biol. 2025 Apr 23;47(5):297. doi: 10.3390/cimb47050297.
2
Interaction networks among miRNA, protein, and metabolite fingerprints identify the regulatory networks and key players in the pathogenesis of diabetic cardiomyopathy.miRNA、蛋白质和代谢物指纹之间的相互作用网络确定了糖尿病性心肌病发病机制中的调控网络和关键因素。
Front Cell Dev Biol. 2025 Jun 30;13:1602320. doi: 10.3389/fcell.2025.1602320. eCollection 2025.
3
Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy.
针对糖尿病肾病中的程序性细胞死亡:从分子机制到药物治疗
Mol Med. 2024 Dec 20;30(1):265. doi: 10.1186/s10020-024-01020-5.
4
Pretreatment can alleviate programmed cell death in mesenchymal stem cells.预处理可减轻间充质干细胞中的程序性细胞死亡。
World J Stem Cells. 2024 Aug 26;16(8):773-779. doi: 10.4252/wjsc.v16.i8.773.
5
Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy.靶向自噬:糖尿病及糖尿病肾病的一种有前景的治疗策略。
Diabetes Ther. 2024 Oct;15(10):2153-2182. doi: 10.1007/s13300-024-01641-3. Epub 2024 Aug 21.